EPIGENOMICS AG
DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the
objective of Europe-wide distribution
2021-06-16 / 17:03
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
=----------------------------------------------------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
Name: Epigenomics AG
Street: Geneststraße 5
Postal code: 10829
City: Berlin
Germany
Legal Entity Identifier (LEI): 549300X1C4U862NDLN97
2. Reason for notification
Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
X Notification is triggered due to the non application of the Custody Exemption available under Sect. 36
Para. 3 No. 2 WpHG
3. Details of person subject to the notification obligation
Legal entity: Morgan Stanley
City of registered office, country: Wilmington, Delaware, United States of America (USA)
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
Morgan Stanley & Co. LLC
5. Date on which threshold was crossed or reached:
10 Jun 2021
6. Total positions
% of voting rights % of voting rights through Total of
attached to shares instruments both in % Total number of voting rights
(total of 7.a.) (total of 7.b.1 + 7.b.2) (7.a. + pursuant to Sec. 41 WpHG
7.b.)
New 4.95 % 0.001268689166 % 4.95 % 11823227
Previous 0.16 % 0.00152242687 % 0.16 % /
notification
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
Direct Indirect Direct Indirect
(Sec. 33 WpHG) (Sec. 34 WpHG) (Sec. 33 WpHG) (Sec. 34 WpHG)
DE000A3H2184 0 584963 0.00 % 4.95 %
Total 584963 4.95 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion Voting rights absolute Voting rights in %
period
0 0.00 %
Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of Expiration or maturity Exercise or conversion Cash or physical Voting rights Voting rights
instrument date period settlement absolute in %
Convertible 29.04.2024 at any time Physical 150 0 %
Bond
Total 150 0.001268689166
%
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other
undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal
entity:
Name % of voting rights (if at % of voting rights through instruments Total of both (if at
least 3% or more) (if at least 5% or more) least 5% or more)
Morgan Stanley % % %
Morgan Stanley Capital % % %
Management, LLC
Morgan Stanley Domestic % % %
Holdings, Inc.
Morgan Stanley & Co. LLC 4.81 % % %
- % % %
Morgan Stanley % % %
Morgan Stanley
International Holdings % % %
Inc.
Morgan Stanley % % %
International Limited
Morgan Stanley Investments % % %
(UK)
Morgan Stanley & Co. % % %
International plc
- % % %
Morgan Stanley % % %
Morgan Stanley Capital % % %
Management, LLC
Morgan Stanley Domestic % % %
Holdings, Inc.
E*TRADE Financial % % %
Holdings, LLC
ETCM Holdings, LLC % % %
E*TRADE Securities LLC % % %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %
10. Other explanatory remarks:
Date
16 Jun 2021
----------------------------------------------------------------------------------------------------------------------- 2021-06-16 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------
Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com
End of News DGAP News Service
=------------ 1208845 2021-06-16
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1208845&application_name=news(END) Dow Jones Newswires
June 16, 2021 11:03 ET (15:03 GMT)
